Genetic Variant in GRM1 Underlies Congenital Cerebellar Ataxia with No Obvious Intellectual Disability
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021551 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Maria S Protasova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Intellectual Disability, Receptors, Metabotropic Glutamate, Spinocerebellar Degenerations. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Metabotropic glutamate receptor 1 (mGluR1) plays a crucial role in slow excitatory postsynaptic conductance, synapse formation, synaptic plasticity, and motor control. The GRM1 gene is expressed mainly in the brain, with the highest expression in the cerebellum. Mutations in the GRM1 gene have previously been known to cause autosomal recessive and autosomal dominant spinocerebellar ataxias. In this study, whole-exome sequencing of a patient from a family of Azerbaijani origin with a diagnosis of congenital cerebellar ataxia was performed, and a new homozygous missense mutation in the GRM1 gene was identified. The mutation leads to the homozygous amino acid substitution of p.Thr824Arg in an evolutionarily highly conserved region encoding the transmembrane domain 7, which is critical for ligand binding and modulating of receptor activity. This is the first report in which a mutation has been identified in the last transmembrane domain of the mGluR1, causing a congenital autosomal recessive form of cerebellar ataxia with no obvious intellectual disability. Additionally, we summarized all known presumable pathogenic genetic variants in the GRM1 gene to date. We demonstrated that multiple rare variants in the GRM1 underlie a broad diversity of clinical neurological and behavioral phenotypes depending on the nature and protein topology of the mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
- Center for Genetics and Life Science, Department of Genetics, Sirius University of Science and Technology, 354340 Sochi, Russia.
- Centre for Genetics and Genetic Technologies, Department of Genetics, Faculty of Biology, Lomonosov Moscow State University, 119192 Moscow, Russia.
- Department of Neurogenetics, Research Center of Neurology, 123367 Moscow, Russia.
- Department of Psychiatry, UMass Chan Medical School, Shrewsbury, MA 01545, USA.
ORCID-Profile: Maria S Protasova, Sergey A Klyushnikov, Sergey N Illarioshkin
Förderung
- Russian Science Foundation
Zitieren
APA
Protasova, M. S., Andreeva, T. V., Klyushnikov, S. A., Illarioshkin, S. N., & Rogaev, E. I. (2023). Genetic Variant in GRM1 Underlies Congenital Cerebellar Ataxia with No Obvious Intellectual Disability. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021551
Vancouver
Protasova MS, Andreeva TV, Klyushnikov SA, Illarioshkin SN, Rogaev EI. Genetic Variant in GRM1 Underlies Congenital Cerebellar Ataxia with No Obvious Intellectual Disability. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021551
BibTeX
@article{Protasova2023,
author = {Protasova, Maria S and Andreeva, Tatiana V and Klyushnikov, Sergey A and Illarioshkin, Sergey N and Rogaev, Evgeny I},
title = {Genetic Variant in GRM1 Underlies Congenital Cerebellar Ataxia with No Obvious Intellectual Disability},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021551}
}
EUVIMED